From Seaweed to Licorice, Innovation Becomes Business

Italian companies are turning to digital twins to streamline production and reduce waste in the pharmaceutical industry.

Italian companies are leveraging digital twins to optimize production and reduce waste in the pharmaceutical industry. This involves creating virtual replicas of production processes to simulate and predict outcomes. By doing so, companies can identify areas for improvement and make data-driven decisions to increase efficiency and reduce environmental impact.

The use of digital twins is becoming increasingly popular in the pharmaceutical industry, where production processes can be complex and variable. By creating a virtual representation of the production process, companies can test and refine their processes without the need for physical prototypes or large-scale production runs.

The adoption of digital twins in the pharmaceutical industry is expected to continue growing as companies seek to improve efficiency and reduce costs while maintaining high-quality production standards.